$20,000 of AGIOS PHARMACEUTICALS lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Sickle Cell policy Biotech innovation Medicaid reform Biotech innovation"
You can find more data on corporate lobbying on Quiver Quantitative.
AGIO Congressional Stock Trading
Members of Congress have traded $AGIO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/17, 01/29 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AGIO Insider Trading Activity
AGIO insiders have traded $AGIO stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by insiders over the last 6 months:
- BRIAN GOFF (Chief Executive Officer) has made 0 purchases and 4 sales selling 31,647 shares for an estimated $1,087,334.
- SARAH GHEUENS (Chief Medical Officer) has made 0 purchases and 7 sales selling 22,919 shares for an estimated $832,296.
- JACQUALYN A FOUSE sold 7,497 shares for an estimated $194,172
- TSVETA MILANOVA (Chief Commercial Officer) has made 0 purchases and 2 sales selling 4,451 shares for an estimated $152,648.
- JAMES WILLIAM BURNS (Chief Legal Officer) sold 2,799 shares for an estimated $93,878
- THEODORE JAMES JR. WASHBURN (Principal Accounting Officer) sold 2,272 shares for an estimated $78,134
- CECILIA JONES (Chief Financial Officer) sold 1,780 shares for an estimated $59,701
- DAVID SCADDEN sold 1,400 shares for an estimated $56,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AGIO Hedge Fund Activity
We have seen 103 institutional investors add shares of AGIO stock to their portfolio, and 114 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COMMODORE CAPITAL LP added 2,185,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $64,020,500
- JEFFERIES FINANCIAL GROUP INC. removed 1,500,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,950,000
- BVF INC/IL removed 1,073,755 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $31,461,021
- BANK OF AMERICA CORP /DE/ added 730,690 shares (+180.5%) to their portfolio in Q1 2025, for an estimated $21,409,217
- SCS CAPITAL MANAGEMENT LLC added 611,098 shares (+inf%) to their portfolio in Q1 2025, for an estimated $17,905,171
- CITADEL ADVISORS LLC removed 570,177 shares (-39.8%) from their portfolio in Q1 2025, for an estimated $16,706,186
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 440,000 shares (+145.2%) to their portfolio in Q1 2025, for an estimated $12,892,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AGIO Analyst Ratings
Wall Street analysts have issued reports on $AGIO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 07/22/2025
- Scotiabank issued a "Sector Outperform" rating on 05/02/2025
- HC Wainwright & Co. issued a "Buy" rating on 02/24/2025
To track analyst ratings and price targets for AGIO, check out Quiver Quantitative's $AGIO forecast page.
AGIO Price Targets
Multiple analysts have issued price targets for $AGIO recently. We have seen 3 analysts offer price targets for $AGIO in the last 6 months, with a median target of $58.0.
Here are some recent targets:
- Greg Harrison from B of A Securities set a target price of $51.0 on 07/22/2025
- Greg Harrison from Scotiabank set a target price of $71.0 on 05/02/2025
- Emily Bodnar from HC Wainwright & Co. set a target price of $58.0 on 02/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
